Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 3Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1Gastrointestinal 1

Conditions

Sarcoma 1Myelodysplastic Syndromes 1Metastasis From Malignant Tumor of Kidney (Disorder) 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Colorectal Neoplasms 1

Interventions

pembrolizumab 409Cyclophosphamide 398Carboplatin 307Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 209Bevacizumab 207fludarabine 195Docetaxel 186Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 121Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Immunotherapy, Active × Clear all
NCT03357276 2019-09-12

Mix Vaccine for Metastatic Colorectal Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03357289 2019-09-12

Mix Vaccine for Metastatic Kidney Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Genitourinary

Metastasis From Malignant Tumor of Kidney (Disorder)

NCT03357315 2019-09-12

Mix Vaccine for Metastatic Sarcoma Patients

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Sarcoma

Sarcoma

NCT01819558 2015-03-20

ALLO-WT1

Institut Paoli-Calmettes

Phase 1/2 Completed
2 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡